4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      New treatments for chronic urticaria

      , , , ,
      Annals of Allergy, Asthma & Immunology
      Elsevier BV

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Chronic urticaria (CU) is a common, heterogeneous, and debilitating disease. Antihistamines and omalizumab are the mainstay therapies of CU. Additional treatment options are needed. Here, we review the off and beyond label use of licensed drugs, novel treatments that are currently under development, and promising new targets.

          Related collections

          Author and article information

          Journal
          Annals of Allergy, Asthma & Immunology
          Annals of Allergy, Asthma & Immunology
          Elsevier BV
          10811206
          August 2019
          August 2019
          Article
          10.1016/j.anai.2019.08.014
          31446134
          ea27f764-141d-48e5-8d1f-3cfb88075b09
          © 2019

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article